• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-424 和 miR-155 在细胞遗传学正常的急性髓系白血病中的失调表达:与 NPM1 和 FLT3 突变状态的相关性。

MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status.

机构信息

Laboratory of Neuro-Oncohematology, Santa Lucia Foundation, Rome, Italy.

出版信息

J Hematol Oncol. 2012 Jun 8;5:26. doi: 10.1186/1756-8722-5-26.

DOI:10.1186/1756-8722-5-26
PMID:22681934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3416574/
Abstract

BACKGROUND

MicroRNA have a central role in normal haematopoiesis and are deregulated in acute myeloid leukaemia (AML). The purpose of the study was to investigate by qRT-PCR the expression of miRNAs involved in myeloid differentiation (miR-424, miR-155, miR-223, miR-17-5p) in 48 patients with cytogenetically normal AML well characterized for NPM1 and/or FLT3 mutations. Three types of normalization were used for the data validation.

FINDINGS

We found that miR-424 was down-modulated in AMLs with NPM1mutA regardless of FLT3 status. On the contrary, miR-155 showed up-regulation in patients with FLT3 internal tandem duplications (ITD) with or without NPM1 mutations. No significant associations were found by analyzing miR-223 and miR-17-5p in relation to FLT3 and NPM1 status.

CONCLUSIONS

This study supports the view that major genetic subsets of CN-AML are associated with distinct miRNA signatures and suggests that miR-424 and miR-155 deregulation is involved in the pathogenesis of CN-AML with NPM1 and FLT3-ITD mutations, respectively.

摘要

背景

MicroRNA 在正常造血过程中起着核心作用,并且在急性髓系白血病(AML)中失调。本研究的目的是通过 qRT-PCR 检测在 48 例核型正常的 AML 患者中涉及髓样分化的 miRNAs(miR-424、miR-155、miR-223、miR-17-5p)的表达情况,这些患者的 NPM1 和/或 FLT3 突变情况得到了很好的描述。为了验证数据,我们使用了三种归一化方法。

结果

我们发现,无论 FLT3 状态如何,NPM1mutA 的 AML 中 miR-424 下调。相反,在有或没有 NPM1 突变的 FLT3 内部串联重复(ITD)患者中,miR-155 上调。在分析 miR-223 和 miR-17-5p 与 FLT3 和 NPM1 状态的关系时,没有发现显著的相关性。

结论

本研究支持这样一种观点,即 CN-AML 的主要遗传亚群与不同的 miRNA 特征相关,并表明 miR-424 和 miR-155 的失调分别涉及 NPM1 和 FLT3-ITD 突变的 CN-AML 的发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210c/3416574/ecbc25358456/1756-8722-5-26-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210c/3416574/1e4e1d497bce/1756-8722-5-26-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210c/3416574/ecbc25358456/1756-8722-5-26-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210c/3416574/1e4e1d497bce/1756-8722-5-26-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/210c/3416574/ecbc25358456/1756-8722-5-26-2.jpg

相似文献

1
MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status.miR-424 和 miR-155 在细胞遗传学正常的急性髓系白血病中的失调表达:与 NPM1 和 FLT3 突变状态的相关性。
J Hematol Oncol. 2012 Jun 8;5:26. doi: 10.1186/1756-8722-5-26.
2
Deregulation of miR-1, miR486, and let-7a in cytogenetically normal acute myeloid leukemia: association with NPM1 and FLT3 mutation and clinical characteristics.细胞遗传学正常的急性髓系白血病中miR-1、miR486和let-7a的失调:与NPM1和FLT3突变及临床特征的关联
Tumour Biol. 2016 Apr;37(4):4841-7. doi: 10.1007/s13277-015-4289-y. Epub 2015 Nov 2.
3
Identification of FLT3 and NPM1 Mutations in Patients with Acute Myeloid Leukaemia.急性髓系白血病患者中FLT3和NPM1突变的鉴定
Asian Pac J Cancer Prev. 2019 Jun 1;20(6):1749-1755. doi: 10.31557/APJCP.2019.20.6.1749.
4
Detection of CD34, TdT, CD56, CD2, CD4, and CD14 by flow cytometry is associated with NPM1 and FLT3 mutation status in cytogenetically normal acute myeloid leukemia.流式细胞术检测 CD34、TdT、CD56、CD2、CD4 和 CD14 与核型正常的急性髓细胞白血病中 NPM1 和 FLT3 突变状态相关。
Clin Lymphoma Myeloma Leuk. 2012 Aug;12(4):274-9. doi: 10.1016/j.clml.2012.01.003. Epub 2012 Apr 4.
5
FMS-Like Tyrosine Kinase 3 (FLT3) and Nucleophosmin 1 (NPM1) in Iranian Adult Acute Myeloid Leukemia Patients with Normal Karyotypes: Mutation Status and Clinical and Laboratory Characteristics.伊朗正常核型成年急性髓系白血病患者中FMS样酪氨酸激酶3(FLT3)和核仁磷酸蛋白1(NPM1):突变状态及临床和实验室特征
Turk J Haematol. 2017 Dec 1;34(4):300-306. doi: 10.4274/tjh.2016.0489. Epub 2017 Mar 15.
6
Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.MN1转录水平的预后重要性,以及细胞遗传学正常的急性髓系白血病中与MN1相关的基因和微小RNA表达特征的生物学见解:一项癌症与白血病B组研究
J Clin Oncol. 2009 Jul 1;27(19):3198-204. doi: 10.1200/JCO.2008.20.6110. Epub 2009 May 18.
7
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.核仁磷酸蛋白 1 突变对细胞遗传学正常的初发急性髓系白血病老年患者具有有利的预后影响及相关的基因和 microRNA 表达特征:一项癌症和白血病组 B 研究。
J Clin Oncol. 2010 Feb 1;28(4):596-604. doi: 10.1200/JCO.2009.25.1496. Epub 2009 Dec 21.
8
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.具有高危分子特征的细胞遗传学正常的急性髓系白血病中CEBPA突变的预后意义以及与之相关的基因和微小RNA表达特征:癌症与白血病B组研究
J Clin Oncol. 2008 Nov 1;26(31):5078-87. doi: 10.1200/JCO.2008.17.5554. Epub 2008 Sep 22.
9
Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.NPM1突变和FLT3内部串联重复在埃及细胞遗传学正常的急性髓系白血病患者中的预后意义
Hematology. 2014 Jan;19(1):22-30. doi: 10.1179/1607845413Y.0000000085. Epub 2013 Nov 25.
10
Differential expression of specific microRNA and their targets in acute myeloid leukemia.急性髓系白血病中特异性 microRNA 的差异表达及其靶基因。
Am J Hematol. 2010 May;85(5):331-9. doi: 10.1002/ajh.21667.

引用本文的文献

1
Immune checkpoints and ncRNAs: pioneering immunotherapy approaches for hematological malignancies.免疫检查点与非编码RNA:血液系统恶性肿瘤的开创性免疫治疗方法
Cancer Cell Int. 2024 Dec 19;24(1):410. doi: 10.1186/s12935-024-03596-8.
2
Role of microRNAs in Chronic Lymphocytic Leukemia.微小 RNA 在慢性淋巴细胞白血病中的作用。
Int J Mol Sci. 2023 Aug 5;24(15):12471. doi: 10.3390/ijms241512471.
3
Overexpression of miR-17 predicts adverse prognosis and disease recurrence for acute myeloid leukemia.miR-17 的过表达预示急性髓系白血病不良预后和疾病复发。

本文引用的文献

1
Current findings for recurring mutations in acute myeloid leukemia.目前急性髓细胞白血病复发性突变的研究结果。
J Hematol Oncol. 2011 Sep 14;4:36. doi: 10.1186/1756-8722-4-36.
2
Integrative nucleophosmin mutation-associated microRNA and gene expression pattern analysis identifies novel microRNA - target gene interactions in acute myeloid leukemia.整合核仁磷酸蛋白突变相关的 microRNA 和基因表达谱分析鉴定急性髓细胞白血病中的新 microRNA-靶基因相互作用。
Haematologica. 2011 Dec;96(12):1783-91. doi: 10.3324/haematol.2011.046888. Epub 2011 Aug 31.
3
Quantitative proteomics identify novel miR-155 target proteins.
Int J Clin Oncol. 2022 Jul;27(7):1222-1232. doi: 10.1007/s10147-022-02161-5. Epub 2022 May 10.
4
Role of Biomarkers in FLT3 AML.生物标志物在FLT3急性髓系白血病中的作用。
Cancers (Basel). 2022 Feb 24;14(5):1164. doi: 10.3390/cancers14051164.
5
Strategies targeting FLT3 beyond the kinase inhibitors.针对 FLT3 的激酶抑制剂以外的策略。
Pharmacol Ther. 2021 Sep;225:107844. doi: 10.1016/j.pharmthera.2021.107844. Epub 2021 Mar 31.
6
Role of microRNA dysregulation in childhood acute leukemias: Diagnostics, monitoring and therapeutics: A comprehensive review.微小RNA失调在儿童急性白血病中的作用:诊断、监测与治疗:综述
World J Clin Oncol. 2020 Jun 24;11(6):348-369. doi: 10.5306/wjco.v11.i6.348.
7
Kras mutations and PU.1 promoter methylation are new pathways in murine radiation-induced AML.Kras 突变和 PU.1 启动子甲基化是小鼠辐射诱导 AML 的新途径。
Carcinogenesis. 2020 Aug 12;41(8):1104-1112. doi: 10.1093/carcin/bgz175.
8
Prognostic and Clinicopathological Significance of MiR-155 in Hematologic Malignancies: A Systematic Review and Meta-analysis.MiR-155在血液系统恶性肿瘤中的预后及临床病理意义:一项系统评价和荟萃分析
J Cancer. 2019 Jan 1;10(3):654-664. doi: 10.7150/jca.28537. eCollection 2019.
9
miR-146 and miR-155: Two Key Modulators of Immune Response and Tumor Development.微小RNA-146和微小RNA-155:免疫反应和肿瘤发展的两个关键调节因子
Noncoding RNA. 2017 Jun 26;3(3):22. doi: 10.3390/ncrna3030022.
10
MicroRNA-155-5p Overexpression in Peripheral Blood Mononuclear Cells of Chronic Lymphocytic Leukemia Patients Is a Novel, Independent Molecular Biomarker of Poor Prognosis.外周血单个核细胞中 microRNA-155-5p 的过表达是慢性淋巴细胞白血病患者的一种新的、独立的预后不良分子标志物。
Dis Markers. 2017;2017:2046545. doi: 10.1155/2017/2046545. Epub 2017 Dec 31.
定量蛋白质组学鉴定新型 miR-155 靶蛋白。
PLoS One. 2011;6(7):e22146. doi: 10.1371/journal.pone.0022146. Epub 2011 Jul 25.
4
Downstream molecular pathways of FLT3 in the pathogenesis of acute myeloid leukemia: biology and therapeutic implications.FLT3 下游分子通路在急性髓系白血病发病机制中的作用:生物学和治疗意义。
J Hematol Oncol. 2011 Apr 1;4:13. doi: 10.1186/1756-8722-4-13.
5
The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.小核仁 RNA 通常用于 miRNA 归一化,与肿瘤病理和预后相关。
Br J Cancer. 2011 Mar 29;104(7):1168-77. doi: 10.1038/sj.bjc.6606076. Epub 2011 Mar 15.
6
The prognostic and functional role of microRNAs in acute myeloid leukemia.miRNAs 在急性髓系白血病中的预后和功能作用。
Blood. 2011 Jan 27;117(4):1121-9. doi: 10.1182/blood-2010-09-191312. Epub 2010 Nov 2.
7
MicroRNAs: emerging key regulators of hematopoiesis.微小 RNA:造血的新兴关键调控因子。
Am J Hematol. 2010 Dec;85(12):935-42. doi: 10.1002/ajh.21863.
8
Differential expression of specific microRNA and their targets in acute myeloid leukemia.急性髓系白血病中特异性 microRNA 的差异表达及其靶基因。
Am J Hematol. 2010 May;85(5):331-9. doi: 10.1002/ajh.21667.
9
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.成人急性髓系白血病的诊断和治疗:代表欧洲白血病网的国际专家小组的建议。
Blood. 2010 Jan 21;115(3):453-74. doi: 10.1182/blood-2009-07-235358. Epub 2009 Oct 30.
10
MicroRNAs: new players in acute myeloid leukaemia.微小RNA:急性髓系白血病中的新角色
Br J Cancer. 2009 Sep 1;101(5):743-8. doi: 10.1038/sj.bjc.6605232. Epub 2009 Aug 11.